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Summary An assessment has been made of the reproducibility of measuring tumour proliferation using in
vivo iododeoxyuridine (IUdR) labelling and flow cytometry. The variation that occurs between different
institutions (Paterson Insitute for Cancer Research, Manchester and the Gray Laboratory, Northwood),
different observers and different runs on the same flow cytometer have been measured on 139 samples from 53
patients with colorectal cancer. The results demonstrate that the IUdR technique for measuring tumour
proliferation is reproducible. Correlations were seen between measurements of Tp> obtained by different
individuals and on separate machines. However, direct comparisons of the measured parameters showed that
there were highly significant differences in the values obtained between institutes and observers (P<0.001).
Despite these variations, there were still significant detectable differences in Tpo, measurements between
individual tumours (P<0.001). Analysis of the results obtained by running the same samples on two separate
occasions on the same machine showed that the technique was highly reproducible and that the staining
procedure was stable. Eighty per cent of the samples were similarly assigned to either above or below the
median Tp,, value, regardless which observer/laboratory combination was utilised. These data suggest that
large clinical trials using Tp, should employ a single centre and a single individual to prepare, run and analyse
samples.
The in vivo incorporation of either of the thymidine
analogues iododeoxyuridine (IUdR) and bromodeoxyuridine
(BUdR) into human tumours in conjunction with flow
cytometry (Begg et al., 1985) allows rapid estimation of the
tumour labelling index (LI), the duration of S phase (Ts) and
hence the potential doubling time (Tpo,). It is hoped this will
be a technique to reliably measure the proliferative rate of
clonogens in an individual's tumour and will provide inform-
ation that could be of clinical use as an independent
indicator of prognosis. It is of particular interest in the
surgical management ofcolorectal cancer as it may be helpful
in the selection of patients for adjuvant treatment. It has
already been suggested that tumours with a short Tpo, may
require an accelerated regime of radiotherapy (Dische &
Saunders, 1989; Begg et al., 1990).
If this technique is to be of use clinically as a predictive
test, it is important to show that the variability with
measurements of Tpo, are smaller than the overall spread of
values. Large assay variability will reduce the predictive
accuracy. In addition, it is useful to assess the reproducibility
of measurements between different institutions and that of
different observers analysing the same stored data. The
precision of DNA flow cytometry has been assessed with
regard to DNA index (Dl) and hyperdiploid fraction (HDF)
between six different institutions (Wheeless et al., 1991). This
study demonstrated that, while there was reasonable concor-
dance of DI values between the institutions, there was
enough intra- and inter-laboratory variation in HDF
measurements to prevent comparison of results between insti-
tutions.
Therefore, a study was initiated to assess the precision of
TP°J measurements on colorectal tumours after in vivo IUdR
labelling. The reliability and reproducibility of the technique
has been determined.
Materials and methods
Patients with colorectal adenocarcinomas (53) were given a
200mg intravenous dose of IUdR (Boehringer Mannheim)
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dissolved in 10 ml of sterile water. This was performed with
informed consent and Hospital Ethical Committee approval.
The tumours were then either biopsied (n = 28) or resected
(n = 25) after a mean interval of 6.2 h (range 3.0-14.7h)
following injection. This interval (t) was measured from the
time of IUdR administration as a bolus over approximately
30s until the cessation of the sample's blood supply. The
samples were then immediately fixed in 70% ethanol and
stored at 4°C. Parallel samples taken from adjacent tissue
were fixed in formol saline for pathological assessment. No
patient had received radio- or chemotherapy prior to IUdR
labelling and tumour sampling.
On the day of analysis, samples were digested to produce a
nuclear suspension and stained for IUdR and total DNA
content as previously described (Wilson et al., 1985). In
summary, the specimens were minced, then digested using
0.4mg ml' pepsin in 0.1 M HCl and the DNA partially
denatured using 2 M HCI for 15 min to expose IUdR-
incorporated DNA. Approximately 2 x 106 nuclei were then
incubated with an anti-IUdR monoclonal antibody (Beckton-
Dickinson) for 1 h at room temperature (1 in 20 dilution).
After washing, the nuclei were incubated with a rabbit anti-
mouse IgG FITC conjugate (Dakopatts) for a further 30 min
(1 in 40 dilution). Finally, the nuclei were counterstained
with propidium iodide at a concentration of 10 gmlm'
(Sigma) to allow measurement of the total DNA content.
The method of data analysis has previously been described
(Wilson et al., 1985). The analyses were performed at the
Gray Laboratory, Northwood on an Ortho Systems 50-H
Cytofluorograph (Beckton-Dickinson) and at the Paterson
Institute for Cancer Research, Manchester, using an EPICS
V flow cytometer (Coulter). Both machines created light with
a wavelength of 488 nm from 5 W argon ion lasers operating
at 200 mW; green fluorescent light emitted by excitation of
the FITC conjugate bound to the anti-IUdR monoclonal
antibody was collected at 510-560 nm and red fluorescence
from the excited PI above 620 nm. All data were collected
from the cytometers on 1024 channels using list mode. The
data analysis requires the use of software which allows
regions (gates) to be set around various populations of par-
ticles. This can be used to remove debris or clumps of
nuclear material from the analyses to facilitate estimations of
the proportions of nuclei within each part of the cell cycle
and their mean DNA content. The data were gated to exclude
multiple nuclei and debris on the DNA peak vs area signals.
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Data for 10,000 to 20,000 nuclei were collected from each
sample. The machines were calibrated before each batch of
analyses using fluorescent beads. Analysis was performed as
described by Begg et al. (1985) using:
(1) TTO, = 0L8 x
where 0.8 is the value assigned to A, a factor which accounts
for the variation in the age structure of the cell (Steel, 1977).
Ts is derived by:
(2)
1.0-0.5
R.M.-0.5
where t is the time period between injection of the IUdR and
tumour biopsy and R.M. is the 'relative movement' of the
labelled nuclei through the cell cycle. This is calculated by
subtracting the mean DNA content of the GI population
from that obtained for the IUdR labelled nuclei and dividing
it by the mean DNA content of the GI subtracted from the
mean of the G2 cells.
(3) R.M. = FL(IUdR) -FLGI
FLG2 + M - FLGJ
Statistical analysis
In all of the individual comparisons, both Spearman's test of
rank correlation (r) and a paired t test were performed. A
hierarchical analysis of variance (ANOVA) was used to allow
for the contribution of each effect to be assessed after all
preceding effects in the model had been fitted. The model
used considered the observer, laboratory and individual sam-
ple effects in that order. Coefficients of variation (CP) were
calculated from the estimated variance for each effect divided
by the mean of all the observations in the dataset. A similar
analysis, using logarithmic regression, was performed to
assess the differences in ploidy (DI= 1 vs DI> 1). A
significance level of 0.05 was used throughout.
Results
Inter-institutional variation
A total of 139 samples from 53 patients were processed and
subsequently analysed at both the Gray laboratory and the
Paterson Insitute by different observers. The values for DI,
LI, RM, Ts and Tpo,, were then compared between the two
centres (Table I and Figures 1 and 2). There was no
significant difference in the ploidy measurement (DI) between
the two laboratories. The ranking of the proliferation values
was similar between both institutions, particularly LI
(r = 0.86) and Tpo, (r = 0.72). However, comparisons between
the two centres with regard to LI, RM, Ts and Tp,,, revealed
significant differences in the numerical values calculated.
Thus, whilst both institutions agreed in terms of classifying
values as high or low, the range ofvalues was different at the
two institutions. The Gray Laboratory Tpot was 6.17 days
whilst that from the Paterson Institute was 4.8 days.
Inter-observer variation
The degree of variation was compared between two individ-
uals independently by analysing the same stored data. The
ungated data from 45 samples at the Gray Laboratory and
68 samples at the Paterson Institute were used to provide
measurements of the DI, LI, RM, Ts and Tpo> as calculated
by two individuals at both institutions (Table II and Figure
3). All of the observers used the same protocol regarding the
decisions required to place the regions around the various
populations of nuclei. The data analysis was always done
without knowledge of which sample was being analysed and
without the assistance of any other individual (Table III).
There was a very good correlation in the ranking of the
samples between two different observers; but as in the
previous comparison there were highly significant differences
in all of the parameters, except DI and LI at the Paterson
Institute. In both the inter-institutional and inter-observer
studies, LI values were better correlated than both RM and
Ts, and the calculated Tp,, values reflected this.
Table I Inter-institutional comparison with different observers, n = 139
Parameter Paterson Inst. mean (range) Gray Lab. mean (range) Correlation Paired t test
D.I. 1.21 (1.00-1.96) 1.21 (1.00-1.96) r=0.74a t= 1.71 NS
L.I. (%) 16.10 (0.90-34.80) 14.10 (0.70-30.60) r = 0.86a t = 5.61 P<0.001
R.M. 0.74 (0.55-0.98) 0.72 (0.57-0.97) r = 0.48a t = 3.4 P = 0.001
T, (hours) 17.51 (4.57-57.50) 19.21 (5.21-59.10) r = 0.52a t = 2.2 P = 0.03
Tpot (days) 4.80 (0.90-27.10) 6.17 (1.30-82.9) r = 0.72a t = 4.0 P = 0.001
ap<.o001.
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Figure 1 The relationship between the LI, Ts and Tp,, values from 139 samples measured at two different institutions by different
observers. The intersecting lines represent the median values. The correlation coefficients (r) were 0.86 (LI), 0.52 (Ts) and 0.72
(TPO)-
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Figure 2 The relationship between the Tpot values under 20 days
measured at two different institutions by different observers.
Correctionfactor
In order to reduce the degree ofvariation seen, attempts were
made to correct for any factor which may differ between
institutions or observers. The 42 samples which had been run
on all of the various observer/laboratory combinations
(Table II) were compared against a standard laboratory/
observer combination which was GW at the Gray Lab. This
combination was chosen as the most established and
experienced one.
Three approaches were assessed on their ability to reduce
the inter-institutional and -observer variation.
(i) Addition or subtraction of a factor equal to the
difference between the mean for each of the lab-
oratory/observer combinations and that of the stand-
ard combination.
(ii) Division of each value by a factor equal to the ratio
of the mean for each laboratory/observer combina-
tion and the mean for the standard.
(iii) A linear regression line was fitted for each of the
laboratory/observer combinations of the value for
that combination against the corresponding value as
the standard. These regression lines were used to
correct each of the experimental values.
Table II IUdR related parameters as measured by the various observer/laboratory combinations on the same 42
samples
LI RM Ts In(T9 In(Tp1t,)
(mean ± s.d.) (mean ± s.d.) (mean ± s.d.) (mean ± s.d.) (mean ± s.d.) (mean ± s.d.)
MW/Gray 13.1, 8.1 0.77, 0.08 13.5, 6.1 2.5, 0.4 5.1, 4.0 1.41, 0.7
GW/Gray 12.6, 7.8 0.72, 0.07 16.9, 7.3 2.8, 0.4 7.0, 6.3 1.7, 0.7
MW/Paterson 13.8, 8.9 0.77, 0.09 13.7, 5.2 2.5, 0.4 4.9, 3.6 1.4, 0.6
CW/Paterson 13.6, 8.3 0.70, 0.09 20.9, 12.0 2.9, 0.6 6.6, 4.3 1.7, 0.5
Table III Inter-observer comparison
Parameter Observer 1, mean (range) Observer 2, mean (range) Correlation Paired t test
Gray lab., n = 45
D.I. 1.23 (1.00-1.94) 1.23 (1.00-1.92) r=1.OOa t=0.6 NS
L.I. (%) 13.1 (1.20-28.7) 12.7 (0.7-29.8) r = 0.99* t = 2.2 P= 0.04
R.M. 0.77 (0.57-0.95) 0.71 (0.57-0.97) r = 0.63a t = 6.1 P<0.001
T, (hours) 14.1 (4.21-46.4) 17.7 (5.2-47.2) r = 0.67a t = 5.7 P<0.001
Tpot (days) 5.15 (1.12-21.9) 8.6 (1.3-82.9) r= 0.87a t = 2.2 P= 0.03
Paterson Inst., n = 68
D.I. 1.18 (1.00-1.96) 1.19 (1.00-1.80) r = 0.84a t = 0.95 NS
L.I. (%) 14.8 (0.9-34.80) 14.5 (0.9-31.20) r = 0.94* t = 1.0 NS
R.M. 0.75 (0.56-0.98) 0.69 (0.54-0.89) r = 0.67a t = 6.7 P<0.001
T, (hours) 16.2 (4.6-53.00) 22.3 (5.2-80.0) r = 0.67a t = 4.4 P<0.001
Tp,t (days) 5.3 (1.1-27.10) 6.7 (1.8-33.2) r = 0.73a t = 5.0 P<0.001
ap<o0.01.
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Figure 3 The relationship between the LI, TS and Tpo, values calculated by two observers using data obtained from 45 samples at
one institution (Gray Lab.). The intersecting lines represent the median values. The correlation coefficients (r) were 0.99 (LI), 0.67
(Ts) and 0.87 (Tpot).
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Figure 4 The relationship between LI, Ts and T.,, values for 30 samples run on two separate occasions on the same machine and
analysed by the same observer. The intersecting lines represent the median values. The correlation coefficients (r) were 0.87 (LI),
0.57 (Ts) and 0.87 (Tp,,)
Correction factors (i) and (ii) both significantly reduced the
laboratory and observer variances for LI and Tpo, but not
those of RM and Ts. Correction factor (ii) reduced the
inter-institutional coefficient of variation from 30 to 2% and
the inter-observer variation from 112 to 62%. Correction
factor (iii) did not appear to reduce the variation of any of
the parameters. Even after correcting the data, the laboratory
and observer differences remained significant except Tpo,
where laboratory difference was not significant. RM and Ts
showed no reduction in either inter-institutional or -observer
variability after such corrections.
Reproducibility
In order to measure the reproducibility of the results
generated by the same machine on the same samples, the
same 30 samples were run on both of the flow cytometers on
two separate occasions following storage at 4°C for 1 week.
The cytometers were re-calibrated before each run of 30
samples. The resulting data were then analysed by the same
individual on both occasions. There was good correlation
between the two samples (e.g.: Tp,,, values, r = 0.74, P<0.001
Gray Lab; r = 0.87, P<0.001 Paterson Inst.) with no statis-
tical difference present in paired analyses of any of the
parameters (Table IV and Figure 4).
Global analysis
Table V demonstrates the coefficients of variation for each of
the IUdR related parameters calculated using hierarchical
ANOVA. This is a global analysis on 457 sets of data that
includes:
(i) 172 samples run at the Paterson Institute and 124
samples run at the Gray Laboratory;
(ii) 62 sets of data reanalysed at the Paterson by two
observers and 39 sets that were reanalysed at the
Gray Lab.;
(iii) 30 samples that were re-run on two occasions on each
flow cytometer.
The 'observer' category represents the variation seen
between the different observers and is fitted first because it
displays the largest variance in Tpo,. LI has a larger variance
in the institute category, which suggests that for this
parameter, there is greater variation between machines than
individual observers. All the following categories (institution,
sample and re-run) are then treated in order, with the varia-
tion due to the preceding categories having been accounted
for. The variation seen in the value for LI is 143% once the
variation due to different observers and institutions have
been included. Both Ts and Tpo, showed skewed distributions
Table IV Machine reproducibility
Correlation
Parameter Run 1, mean (range) Run 2, mean (range) (significance)
Gray lab.? n = 30
DI 1.19 (1.00-1.77) 1.21 (1.00-1.69) r= 1.00 P<0.001
LI (%) 16.1 (2.9-34.6) 15.9 (3.2-29.8) r = 0.98 P<0.001
RM 0.73 (0.57-0.89) 0.73 (0.59-0.92) r = 0.40 P = 0.012
T, (hours) 17.6 (6.2-53.1) 17.4 (8.8-47.2) r = 0.57 P<0.001
Tpot (days) 4.6 (1.7-17.5) 4.7 (1.3-19.2) r=0.74 P<0.001
Paterson lab., n = 30
DI 1.20 (1.00-1.64) 1.19 (1.00-1.64) r= 0.88 P<0.001
LI (%) 18.3 (3.9-34.8) 18.3 (4.4-34.7) r = 0.87 P<0.001
RM 0.75 (0.63-0.92) 0.77 (0.63-0.91) r = 0.54 P = 0.001
T, (hours) 15.8 (6.5-25.0) 14.9 (6.1-29.5) r = 0.76 P<0.001
Tpot (days) 3.5 (0.9-9.1) 3.3 (0.9-9.0) r = 0.87 P<0.001
Table V Coefficients of variation (%) of the IUdR related
parameters
LI RM Ts In(Ts) Tpot In(Tp.1)
Observer 91.4 39.2 165.9 48.4 181.6 131.1
Institute 132.0 20.0 98.3 44.3 104.4 44.0
Sample 142.5 24.3 101.4 37.1 241.5 103.2
Re-runs 27.8 7.8 39.9 10.3 41.5 24.9
c
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and therefore a logarithmic transformation was applied to
these variables. The un-transformed values are also shown to
allow comparison with published results from other studies.
This analysis indicates that there are highly significant
differences between different samples once the variation due
to different observers and institutions have been taken into
account. The estimates of ploidy (diploid vs aneuploid) show
no significant differences between observers (P = 0.11) or
institutions (P = 0.12), but highly significant differences
between individual tumours (P<0.001). Once these effects
are allowed for, 92% of the samples are correctly categorised
into above or below the median value.
Discussion
Cell proliferation kinetics have been shown to be a prognos-
tic factor for several types of cancer as reviewed by Tubiana
& Courdi (1989). These studies have been carried out using
either tritiated thymidine labelling or flow cytometric
measurements of S-phase fractions. The first method is time
consuming and has limited clinical application due to the
requirement for the administration of a radioactive isotope.
The second method may over-estimate proliferative capacity
as there is evidence that cells can arrest in phases other than
GI (Drewinko et al., 1984). Furthermore, it is difficult to
exclude the normal stromal nuclei from the analysis. The
development of a monoclonal antibody to the halogenated
pyrimidines IUdR and BUdR (Gratzner, 1982), allowed the
establishment of a rapid technique for the simultaneous
measurement of tumour DNA content, labelling index (LI)
and an estimation of the duration of S-phase (Ts). These
measurements provide the basis for the calculation of Tp,,,.
Although there are several clinical studies published using
this technique on a variety of tumour types (Wilson et al.,
1988; Begg et al., 1990; Rew et al., 1991; Riccardi et al.,
1991; Rew et al., 1992), the reliability and reproducibility of
the method has yet to be examined in detail.
It has been demonstrated that the measurement of ploidy
may be performed accurately both between and within insti-
tutions (Wheeless et al., 1991). This study confirms the
finding in that there are no significant differences in ploidy
determinations between the present institutions, individuals
analysing the same stored data and in samples re-run on the
same machine. As regards the other IUdR-related parameters
(LI, RM, Ts and Tp,0), these measurements were not as
closely reproducible.
A comparison of the values obtained by running samples
on two separate machines and analysed by different observers
showed that there were significant differences in the measured
parameters. However, most results were well correlated, i.e.:
there was good agreement that a given sample had a high or
low LI, RM, Ts or Tpot value. The best correlations were seen
in the measurements of LI (r = 0.86) and Tpot (r = 0.72).
However, correlations for RM (0.48) and Ts (0.52) were not
as strong.
Significant but less marked variation was seen between
observers analysing the same stored data. In this case values
for LI were not significantly different and the correlation
coefficients obtained were higher than for the inter-
institutional comparison. The differences seen in measured
values for RM, Ts and Tp,t are likely to represent discrepan-
cies in delineating GI, S and G2. All three of the data
analysers used the same previously agreed criteria on where
to define the various regions, and all obtained G2 from the
2D histograms. It may be that the degrees of correlation
obtained could be improved, either by arbitrarily defining G2
as simply twice G, or by using the ID histogram, which often
displays G2 more visibly. Defining the G2:GI ratio as two has
been used in previous studies (e.g. Begg et al., 1988). In the
present study, this had the effect oflengthening the calculated
Tpo,0 values and made the determination of Tpot impossible in
two cases as the RM value dropped below 0.5. The scatter, as
indicated by the correlation between two individuals, was
greater if the G2:GI ratio was assumed to be 2 (e.g. r
= 0.70
vs 0.92). This indicates that arbitrarily attributing a value to
G2 makes the measurement less accurate. It should be noted
that there have been attempts to improve the calculation of
Ts by a more rigorous mathematical method (White & Meist-
rich, 1986; White, 1989; White et al., 1990). However, com-
parisons of these sophisticated approaches with the more
simple RM method (Begg et al., 1985) suggest that the
difference in Tpot calculated is small and identification of the
appropriate regions is easier with the RM method (Wilson &
McNally, 1991).
Although the actual values obtained were significantly
different between different institutions and observers, there
was good agreement in the ranking of the results. Attempts
were made to reduce the degree of variation seen in the
comparisons using a correction factor. This was considered
and three mathematical models were assessed using pooled
results of 42 samples which had been run on all of the
various observer/laboratory combinations. The greatest
reduction in variance was seen after correction by a factor
corresponding to the ratio between any given observer/
institute combination and a 'gold standard' which was GW at
the Gray Laboratory. This was chosen due to the greatest
experience of that combination. By doing this it was possible
to reduce the Tpo, CV between institutes from 30 to 2%,
whereupon the variation was not significantly different.
Reduction in the inter-observer variation was from 112 to
62% but this remained a highly significant degree of
variability (P<0.001). These results indicate that, whilst
there is good agreement between different institutions and
observers analysing stored data in deciding the ranking of
Tpot values, the actual numerical values for Tp,0 are
significantly different. The former may be totally correctable,
the latter only partially i.e. it is not possible to use a
mathematical factor to remove all of the variation between
laboratories and observers. This demonstrates the difficulties
of pooling data and supports the concept that in a com-
parative cell kinetic study a single individual should be res-
ponsible for the preparation and analysis of the samples
using a single flow cytometer.
The degree of machine reproducibility was tested by re-
analysing nuclei from 30 specimens stored for 1 week at 4°C
in the dark. There were no significant differences in the
measured values obtained, illustrating both the reproduc-
ibility of the technique and the efficacy of sample storage for
a short period of time. A further source of variability is the
presence of heterogeneity with in individual tumours. This
particular problem has been previously addressed (Begg et
al., 1988; Rew et al., 1991) and forms the basis of a paper
presently being produced.
The median Tp,,0 value has been previously used as a
watershed to determine if a tumour is a fast or slow pro-
liferator (Begg et al., 1990). Despite the variation demon-
strated in this study, the percentage of samples where there
was agreement in their position above or below the median
was 77% between different observers, 89% between different
institutions and 87% between different runs on the same
machine/observer combination. Eighty per cent of the sam-
ples were consistently placed either above or below the
median, irrespective of which particular observer/laboratory
combination was used.
In conclusion, we have demonstrated that the IUdR techni-
que for measuring tumour proliferation is reproducible. The
variation in the assay is far less than that seen between
individual tumours. Correlations were seen between the
measurements of obtained by different individuals and on
separate machines. These were good for DI, LI and Tp,0 and
weakest for RM and Ts suggesting that the main source of
variability is from the RM measurements which are used to
calculate Ts and subsequently T,,o Direct comparisons of the
actual measured values showed that there were highly
significant differences in the values obtained between in-
stitutes and observers. Thus, whilst the institutions/observers
agreed in terms of classifying values as high or low, the
ranges of values were different. These data suggest that large
clinical trials using Tp,,0 should use a single centre and a singleEVALUATION OF Tpt IN COLORECTAL CANCER 759
experienced individual to prepare, run and analyse samples.
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